| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Medical Officer | SVP, Chief Medical Officer
1 company
Young Diane C. serves as a SVP, Chief Medical Officer at CLDX. Across recent SEC filings that breaks down to 1 buy and 3 sells. Those positions are worth an estimated $46K at current prices.
Historically, Young Diane C.'s trades have earned a middling insider score of 63/100 across 3 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +22.8%.
The biggest single holding is CLDX (~$46K) as SVP, Chief Medical Officer. The recent filings there lean toward selling, a net 66,485 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2024 | CLDX Celldex Therapeutics, Inc. | SVP, Chief Medical Officer | Sell | 45,000 | $35.26 | $1,586,844.00 | -95.5% | +23.2% | -39.5% | |
| Aug 17, 2022 | CLDX Celldex Therapeutics, Inc. | SVP, Chief Medical Officer | Sale+OE | 19,000 | $37.30 | $708,715.20 | -90.0% | -0.1% | -18.8% | |
| Nov 12, 2021 | CLDX Celldex Therapeutics, Inc. | SVP, Chief Medical Officer | Sale+OE | 4,600 | $42.94 | $197,529.06 | -68.5% | -24.3% | -10.2% | |
| Jun 11, 2020 | CLDX Celldex Therapeutics, Inc. | SVP, Chief Medical Officer | Buy | 2,115 | $4.73 | $10,003.95 | New | - | - |